Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
OBJECTIVE: Clinicians have few evidence-based options for the management of treatment-resistant bipolar depression. This study represents the first randomized trial of competing options for treatment-resistant bipolar depression and assesses the effectiveness and safety of antidepressant augmentati...
Main Authors: | Nierenberg, A, Ostacher, M, Calabrese, JR, Ketter, T, Marangell, L, Miklowitz, D, Miyahara, S, Bauer, MS, Thase, M, Wisniewski, SR, Sachs, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2006
|
Similar Items
-
Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD.
by: Marangell, L, et al.
Published: (2004) -
Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
by: Perlis, R, et al.
Published: (2006) -
Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
by: Bauer, MS, et al.
Published: (2006) -
Effectiveness of adjunctive antidepressant treatment for bipolar depression.
by: Sachs, G, et al.
Published: (2007) -
Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study.
by: Perlis, R, et al.
Published: (2010)